Dercum’s Disease Market Research Report – Forecast to 2027

Dercum’s Disease Market Research Report: by Treatment (Surgery, Medication, Liposuction, Electrotherapy, Acupuncture, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By End-User (Hospital & Clinics, Others) - Forecast Till 2027

ID: MRFR/Pharma/4889-HCR | | Region: Global | 90 Pages         

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Dercum’s Disease Market, by Treatment

6.1 Introduction

6.2 Surgery

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3 Medication

6.3.1 Diuretics

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.2 Non-Steroidal Anti-Inflammatory Drugs

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.3 Corticosteroids

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.3.4 Others

6.4 Liposuction

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.5 Electrotherapy

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.6 Acupuncture

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

6.7 Others

Chapter 7. Global Dercum’s Disease Market, by Distribution Channel

7.1 Introduction

7.2 Retail Pharmacies

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

7.3 Hospital Pharmacies

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

7.4 Others

Chapter 8. Global Dercum’s Disease Market, by End-User

8.1 Introduction

8.2 Hospital & Clinics

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8.3 Ambulatory Surgical Centers

Market Estimates & Forecast, by Region, 2019–2027

Market Estimates & Forecast, by Country, 2019–2027

8.4 Others

Chapter 9. Global Dercum’s Disease Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Pfizer, Inc.

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 AbbVie, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Merck & Co., Inc.

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Johnson & Johnson Services, Inc.

11.4.1 Company Overview

11.4.2 Product Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 GlaxoSmithKline plc

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Novartis

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Acorda Therapeutics, Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 F. Hoffman La Roche AG

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Eli Lily and Company

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 AstraZeneca Plc

11.10.1 Overview

11.10.2 Product Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis

11.11 Amgen

11.11.1 Overview

11.11.2 Product Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

11.12 Valeant Pharmaceuticals

11.12.1 Overview

11.12.2 Product Overview

11.12.3 Financials

11.12.4 Key Developments

11.12.5 SWOT Analysis

11.13 Syneron Medical

11.13.1 Overview

11.13.2 Product Overview

11.13.3 Financials

11.13.4 Key Developments

11.13.5 SWOT Analysis

11.14 St. Jude Medical Inc.

11.14.1 Overview

11.14.2 Product Overview

11.14.3 Financials

11.14.4 Key Developments

11.14.5 SWOT Analysis

11.15 Alimed Inc.

11.15.1 Overview

11.15.2 Product Overview

11.15.3 Financials

11.15.4 Key Developments

11.15.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Dercum’s Disease Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Dercum’s Disease Market Synopsis, 2019–2027

Table 2 Global Dercum’s Disease Market Estimates and Forecast, 2019–2027 (USD Million)

Table 3 Global Dercum’s Disease Market, by Region, 2019–2027 (USD Million)

Table 4 Global Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 5 Global Dercum’s Disease Market, by Distribution Channel, 2019–2027(USD Million)

Table 6 Global Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 7 North America: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 8 North America: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 9 North America: Dercum’s Disease Market, by End-User, 2019–2027 (USD

Million)

Table 10 US: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 11 US: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)

Table 12 US: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 13 Canada: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 14 Canada: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)

Table 15 Canada: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 16 South America: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 17 South America: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 18 South America: Dercum’s Disease Market, by End-User, 2019–2027 (USD

Million)

Table 19 Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 20 Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD Million)

Table 21 Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 22 Western Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 23 Western Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 24 Western Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD

Million)

Table 25 Eastern Europe: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 26 Eastern Europe: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 27 Eastern Europe: Dercum’s Disease Market, by End-User, 2019–2027 (USD

Million)

Table 28 Asia-Pacific: Dercum’s Disease Market, by Treatment, 2019–2027 (USD Million)

Table 29 Asia-Pacific: Dercum’s Disease Market, by Distribution Channel, 2019–2027 (USD

Million)

Table 30 Asia-Pacific: Dercum’s Disease Market, by End-User, 2019–2027 (USD Million)

Table 31 Middle East & Africa: Dercum’s Disease Market, by Treatment, 2019–2027

(USD Million)

Table 32 Middle East & Africa: Dercum’s Disease Market, by Distribution Channel, 2019–2027

(USD Million)

Table 33 Middle East & Africa: Dercum’s Disease Market, by End-User, 2019–2027

(USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Dercum’s Disease Market

Figure 3 Segmentation Market Dynamics for Global Dercum’s Disease Market

Figure 4 Global Dercum’s Disease Market Share, by Treatment, 2019

Figure 5 Global Dercum’s Disease Market Share, by Distribution Channel, 2019

Figure 6 Global Dercum’s Disease Market Share, by End-User, 2019

Figure 7 Global Dercum’s Disease Market Share, by Region, 2019

Figure 8 North America: Dercum’s Disease Market Share, by Country, 2019

Figure 9 Europe: Dercum’s Disease Market Share, by Country, 2019

Figure 10 Asia-Pacific: Dercum’s Disease Market Share, by Country, 2019

Figure 11 Middle East & Africa: Dercum’s Disease Market Share, by Country, 2019

Figure 12 Global Dercum’s Disease Market: Company Share Analysis, 2019 (%)

Figure 13 Pfizer, Inc.: Key Financials

Figure 14 Pfizer, Inc.: Segmental Revenue

Figure 15 Pfizer, Inc.: Geographical Revenue

Figure 16 AbbVie, Inc.: Key Financials

Figure 17 AbbVie, Inc.: Segmental Revenue

Figure 18 AbbVie, Inc.: Geographical Revenue

Figure 19 Merck & Co., Inc.: Key Financials

Figure 20 Merck & Co., Inc.: Segmental Revenue

Figure 21 Merck & Co., Inc.: Geographical Revenue

Figure 22 Johnson & Johnson Services, Inc.: Key Financials

Figure 23 Johnson & Johnson Services, Inc.: Segmental Revenue

Figure 24 Johnson & Johnson Services, Inc.: Geographical Revenue

Figure 25 GlaxoSmithKline plc: Key Financials

Figure 26 GlaxoSmithKline plc: Segmental Revenue

Figure 27 GlaxoSmithKline Plc. Geographical Revenue

Figure 28 Novartis: Key Financials

Figure 29 Novartis: Segmental Revenue

Figure 30 Novartis: Geographical Revenue

Figure 31 Acorda Therapeutics, Inc.: Key Financials

Figure 32 Acorda Therapeutics, Inc.: Segmental Revenue

Figure 33 Acorda Therapeutics, Inc.: Geographical Revenue

Figure 34 F. Hoffman La Roche AG: Key Financials

Figure 35 F. Hoffman La Roche AG: Segmental Revenue

Figure 36 F. Hoffman La Roche AG: Geographical Revenue

Figure 37 Eli Lily and Company: Key Financials

Figure 38 Eli Lily and Company: Segmental Revenue

Figure 39 Eli Lily and Company: Geographical Revenue

Figure 40 AstraZeneca Plc: Key Financials

Figure 41 AstraZeneca Plc: Segmental Revenue

Figure 42 AstraZeneca Plc: Geographical Revenue

Figure 43 Amgen: Key Financials

Figure 44 Amgen: Segmental Revenue

Figure 45 Amgen: Geographical Revenue

Figure 43 Valeant Pharmaceuticals: Key Financials

Figure 44 Valeant Pharmaceuticals: Segmental Revenue

Figure 45 Valeant Pharmaceuticals: Geographical Revenue

Figure 46 Syneron Medical: Key Financials

Figure 47 Syneron Medical: Segmental Revenue

Figure 48 Syneron Medical: Geographical Revenue

Figure 49 St. Jude Medical Inc.: Key Financials

Figure 50 St. Jude Medical Inc.: Segmental Revenue

Figure 51 St. Jude Medical Inc.: Geographical Revenue

Figure 52 Alimed, Inc.: Key Financials

Figure 53 Alimed, Inc.: Segmental Revenue

Figure 54 Alimed, Inc.: Geographical Revenue

Dercums Disease Market Speak to Analyst Request a Free Sample

Decrum's Disease Market Overview:


The decrum's disease market is one of the rapidly improving market structures which is projected to achieve better future results due to the rising number of cases of decrum's disease surgeries which leads to continuous investments being made towards the establishment and growth of the healthcare sector and the treatment services to overcome decrum's disease.


Decrum’s disease which is also known as adipose Dolorosa is a temporary physical disability that affects the lipomas in the body and is often observed as painful growth of the tissues that causes pain in the upper arms and upper legs of the patient. It is observed that it commonly affects women and that too it is very hard to find a treatment for the disease. However, continuous research is being carried on in the healthcare sector to find a permanent solution to this problem.


The basic decrum’s disease symptoms that are common to be found are weight gain, swelling in body parts, depressions, difficulty in sleeping, fatigue, weakness, shortage of breath, rapid heart rate, and others which provide clear signs that a person might be suffering from the disease and hence needs treatment for decrum’s disease. The continuous advancement in technology and rapid globalization in the health sector has provided a boost to the global decrum’s disease market in finding out treatment for the disease.


The global decrum's disease market is expected to grow at a CAGR of around 7.1%. The decrum's disease market is expected to reap positive results from the Asia Pacific region where the continuous research and development processes and increased expenditure on the healthcare sector have boosted the growth of treatment of decrum’s disease. Moreover, the segment by end-user is expected to contribute maximum towards decrum's disease treatment market share.


COVID 19 Analysis of Decrum's Disease Market:


The novel coronavirus or the Covid 19 pandemic has negatively impacted the decrum's disease industry since the rising number of decrum's disease cases have been affected since the healthcare service providers and frontline workers are focussed more on handling the upcoming covid cases which have reduced the significant consideration being paid to the decorum’s disease. Due to the lockdowns in various countries, the demand for treatment of decrum's disease has significantly reduced due to restriction of people in moving freely and also people avoiding much of their visits to the health care places until there’s an emergency. Due to the Covid 19 effect, it has been observed that a large number of companies are forced to lay off employees but it is assumed that the market will soon pick up the pace and the demand would increase. It is expected that the post-lockdown period would be a great success for the treatment of decorum’s disease since more stress would be laid on research and samples to be collected. It is also analyzed that every segment would be contributing significantly towards the growth of decrum's disease treatment market value.


Decrum's Disease Market Dynamics


Drivers:


The decrum's disease market has been experiencing a diversified growth in all segments and across different regions due to the rising populations and the increasing per capita incomes of people which has shifted the demands of people to highly sophisticated and technologically advanced products and equipment which have acted as a motivating factor to the decrum's disease market.


Secondly, the growing cases of lipomas have acted as a major key driver since the reporting of decrum’s disease cases have increased in the past decade especially among women which have provided a roadway to the global health care companies to find treatment for decrum’s disease. The increased research and development in the treatment for decrum’s disease have contributed towards the growth of decrum's disease market.


Another major driver in the global decrum's disease market has been the ever-increasing health awareness programs and missions which have motivated people all over the world towards improvement in their health stats and to also be aware of the diseases that can be caused due to the consumption of various products. Also, the improvement in health care facilities all around the world has facilitated the decrum's disease market to have a vast growth.


Restraints:


The overall growth in the decrum's disease market has been expediently rising but certain factors hinder the growth process of the market which include large sums of money to be invested initially in setting up of decrum's disease treatment and medicinal companies and thus it restricts various new players to enter the decrum's disease markets.


Another key factor that acts as a barrier towards an increase in decrum's disease treatment market share is the lack of awareness among the people about the disease. In western countries, people are becoming aware of the disease but in developing nations, people are unaware of the disease which is a major threat to the market. Also, the symptoms are too common for people to realize the urgency of the situation for the treatment of disease.


Another key restraint that has been observed off late is the high cost of the decrum's disease treatment which bars most of the patients who are not aptly equipped with all the financial resources and also affects the decrum's disease treatment market share since it cannot cater to the diverse variety of patients of different sections of the society.


Technology Analysis:


The decrum's disease market trends have been dedicated towards the use of improved technology in the treatment process since the procedure for decrum's disease treatment is based on highly scientific procedures and methods, it is usually carried on with the help of advanced tools and machines.


However, to be more specific, decrum's disease procedure involves the use of biopsy in the initial stages to understand the condition of the lipomas after which the diagnosis process is established which involves the liposuction technique, electrotherapy technique, and the acupuncture technique to provide a cure for the decrum’s disease. Thus, the technical aspects in the treatment of decrum’s disease have played a vital role in the growth of the market and are also being continuously developed.


The technological system to be used in the near future in the decrum's disease treatment market involves using robotics and the artificial intelligence systems to provide for the specific and timely location of cancer and then proceed with the treatment process and to remove the fatty tissues by minimizing every threat associated with the treatment and also ensuring that the decrum’s disease does not reoccur.


Study Objectives:



  • To analyze the trends that are prevalent in the global decrum's disease market regions and players that will dominate the global trends and lead the decrum's disease market operations towards growth figures that have been predicted by the prominent leaders in the international market and key experts for the ongoing forecast period that ends in 2028.

  • To understand the scale of functioning of the global decrum's disease market segments that are prevalent through their ability to meet the vibrant needs of the target audience for market products and services.

  • To draw a competitive scale amongst the global decrum's disease market players and to understand the recent developments of the key decrum's disease market  players in the recent past that promise great results to the market for the ongoing forecast period and automotive refinishcoating market trends that end in 2028.  


Segment Overview:


The decrum's disease market has been segmented as follows:


By treatment



  • Surgery

  • Medication

  • Liposuction

  • Electrotherapy

  • Acupuncture

  • others


By distribution channel,



  • retail pharmacies

  • hospital pharmacies



  • By end-user



  • hospital & clinics

  • ambulatory surgical centers

  • others


 By Region


North America



  • The U.S.

  • Canada

  • Mexico 


Europe



  • Germany

  • France

  • UK

  • Italy 


 Asia-Pacific



  • Japan

  • China

  • Australia

  • India 


LAMEA



  • Brazil

  • Saudi Arabia

  • South Africa


Regional Analysis:


The global decrum's disease market has been divided into four regions where each region has been contributing significantly in terms of its capabilities and population demands. However, among the four regions, the Asia Pacific region has been accounting for the major decrum's disease treatment market share whereby the key drivers towards the growth of the decrum's disease treatment industry are developed here since a variety of researches taking place in these countries and continuous investment being made towards the growth of the health sector.


The major decrum's disease treatment market revenue is expected to come from countries like China, Japan, Korea, and India. The decrum's disease statistics indicate that the population along with the disposable incomes of people of these countries has been increasing which has led to shifts in lifestyles and changing demands. The shift of the people towards health awareness has contributed towards the growth of the market in this region.


The European region has also been experiencing major growth with contributions coming from developed nations such as France, Germany, Denmark, Belgium, etc. due to the increased expenditure made by the Governments of these countries towards research and developments in the health sector. The North American region is also experiencing vast growth in decrum's disease treatment market as the countries in this region have been reaping the benefits of technology thereby maximizing the level of operations and reducing operational costs and also the people in these countries have also generated awareness regarding the decorum’s disease.


Competitive Landscape:


The competitive landscape in terms of the decrum's disease market has been immense and nail-biting with new players easily entering the market and the existing players making huge investments in this segment.



  • AbbVie Inc.

  • GlaxoSmithKline Plc

  • Merck & Co. Inc.

  • Novartis AG

  • Hoffmann La Roche Ltd.

  • Bausch Health Companies Inc.

  • AstraZeneca

  • Eli Lilly and Company

  • Sanofi

  • Amgen Inc. 


The key players in the market are more focused on developing future strategies and set themselves as joint ventures to increase the decrum's disease market share and size.


Recent Developments:


Recently, Raziel Therapeutics, a pharmaceutical company has announced its agreement with Fosun Pharma, a leading pharmaceutical company in china for licensing of disrupting technology of RZL 012 which is analyzed to be one such drug to cure the decrum’s disease. This would boost the market for both companies.


Earlier this year, the Israeli VC firm Pontifax along with Catalyst funds, Quark ventures, and Peregrine ventures provided funds to the pharmaceutical company Raziel therapeutics for its development of the drug to be used as a cure for the decrum’s disease.


Report Overview: 


The Global report helps the investors to gain meaningful information about the decrum's disease treatment market and make decisions wisely. The report discusses the steps taken by the decrum's disease market leaders to boost the market growth and inflate market valuation for their good. The report fully summarises the ongoing market scenario in the decrum's disease market which would help the intended audience to seek more information about the market. The objective of the report was to fully summarise the key players in the market and their role in boosting the decrum's disease market value. The report also discusses the future growth prospects and the competitive landscape in the decrum's disease treatment industry and lays down the expected growth rate of the market along with the hindrances it may face.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: Significant value
  CAGR   2020–2027: Substantial CAGR
  Base Year   2019
  Forecast Period   2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Treatment, By Distribution Channel, By End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Pfizer, Inc., Abbvie, Inc., Johnson & Johnson, GlaxoSmithKline Plc, Merck & Co., Inc., Novartis, Hoffman, La Roche AG, Eli Lily and Company, AstraZeneca PLC, Amgen, Valeant Pharmaceuticals, Syneron Medical, St. Jude Medical Inc. and Alimed, Inc.
  Key Market Opportunities

  • Rising prevalence of rare diseases
  • Growing occurrences of lipomas
  • Rising research and development activities
  •   Key Market Drivers   Growing healthcare expenditures in the developed as well as developing economies


    Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The major factor to impact dercum disease market is lack of awareness.

    Developing economies, surge in occurrences of lipomas, and increasing funding for research and development activities would ensure better dercum disease market growth.

    Dercum disease market report has end users like ambulatory surgical centers, hospital & clinics, and others.

    The distribution channel includes hospital pharmacies, retail pharmacies, and others for the study of dercum disease market.

    The report has treatments like acupuncture, medication, surgery, electrotherapy, liposuction, and others.